More answers like this
Grok 4.5Nov 6, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or widespread health crisis, though it has significant capabilities and has made improvements since COVID-19. Major gaps in coordination, funding, stockpiles sustainability, trust, equity, and sustained political commitment leave it vulnerable, and recent policy shifts have raised further concerns.[1]

The US ranks first globally in the Global Health Security (GHS) Index (score of ~83.5/100 out of 195 countries), reflecting strong lab systems, surveillance/reporting, biosafety/biosecurity, emergency planning frameworks, risk communication infrastructure, and medical countermeasure approval capacity. It outperforms averages substantially in prevention, detection, and international norms compliance.[1][2]

Post-COVID Improvements

The Biden administration (and prior efforts) rebuilt elements of readiness:

•Strategic National Stockpile (SNS): Dramatically increased PPE (e.g., 70x N95s, 34x gloves, 50x gowns) and ventilators compared to pre-COVID levels; supported responses to H5N1 and mpox.[3]
•Surveillance and data: Expanded electronic case reporting (from ~200 facilities pre-COVID to over 45,000–48,000), syndromic surveillance in most EDs, wastewater monitoring, and a “One CDC” data platform.[4]
•Coordination and policy: Created the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023; released National Biodefense Strategy, Global Health Security Strategy (2024), and a detailed roadmap/playbook; invested billions in global health security, vaccine/therapeutic development (including mRNA platforms and 100-days mission concepts), and partner country capacity.[5][6][3]
•Countermeasures and manufacturing: Advances via BARDA/ASPR, warm-base lab contracts, and stockpiling (e.g., H5N1 vaccine doses). Responses to mpox and H5N1 showed some operational gains.[7]
•CDC and ASPR have prioritized response readiness frameworks based on COVID lessons.[4]

These built on decades of investments (e.g., PAHPA authorizations) and private-sector/academic strengths in R&D and manufacturing.

Persistent and Emerging Gaps

Independent assessments highlight unfinished business:

•Bipartisan Commission on Biodefense (2024 National Blueprint): The US remains “dangerously vulnerable.” COVID exposed failures to implement prior recommendations; biological threats (natural, accidental, deliberate) are growing due to climate, technology (e.g., AI-enabled bioweapons risks), and zoonoses (e.g., H5N1 in cattle). It calls for immediate action on leadership, intelligence/attribution, S&T, preparedness, detection/surveillance, and response/recovery, with dozens of recommendations. Fragmentation persists across agencies.[8][9]
•GAO findings: Hundreds of COVID-related recommendations remain open (e.g., ~220 of ~450 as of mid-2024). Issues include HHS leadership/coordination of emergencies, IT/data system duplication and privacy, medical countermeasure manufacturing risks, interagency exercise follow-through, and public health situational awareness. Coordination between PHEP (public health) and HPP (hospital) programs needs improvement.[10][11]
•Funding shortfalls: PHEMCE estimates multi-billion-dollar gaps for countermeasures (e.g., projected $46B shortfall for 2023–2027 needs). PAHPA reauthorization has faced delays/lapses; state/local public health funding is uneven or declining post-COVID supplemental funds.[12]
•Operational and systemic weaknesses: Healthcare surge capacity, equity/access disparities, supply chain vulnerabilities (many APIs foreign-sourced), antimicrobial resistance, low vaccination rates for some diseases, and trust/misinformation issues. State preparedness varies widely (TFAH reports show many in middle/low tiers). H5N1 response drew criticism for incomplete animal testing, farmer cooperation, and One Health (human-animal) integration.[13][14]
•Global interdependence: Diseases ignore borders. US investments helped create tools like JYNNEOS (mpox) and supported the Pandemic Fund, but withdrawal from or rejection of WHO IHR amendments/pandemic-related efforts, plus cuts to global programs, weakens early warning and containment abroad.[15]

Recent Developments and Risks (as of 2025–2026 context)

Reports indicate the second Trump administration (with RFK Jr. at HHS) has scaled back or dismantled key elements: emptying or understaffing OPPR and related NSC roles; terminating or winding down substantial mRNA and other countermeasure R&D contracts (hundreds of millions to over $1B impacted); cuts to surveillance, NIH/NIAID pandemic portfolios, and global health security; staff reductions at HHS/CDC/ASPR; and skepticism toward certain vaccines/platforms. Experts describe this as damaging preparedness and creating gaps adversaries could exploit, while other countries partially fill voids. PAHPA modernization and hospital preparedness funding face uncertainty.[16][17][18]

Public health infrastructure was already strained; polarization, burnout, and eroded trust compound risks. No country is fully prepared (GHS Index average is low), and the next threat (e.g., novel virus, engineered pathogen, or severe flu) may differ from COVID.

Bottom Line

The US has world-leading scientific, industrial, and (on paper) planning strengths, plus rebuilt stockpiles and data tools that make it better positioned than in early 2020 for some scenarios. However, it is not adequately prepared overall due to incomplete implementation of lessons, chronic underfunding/coordination issues, variable state capacity, and recent erosions in R&D, coordination offices, and global engagement. Experts across bipartisan commissions, GAO, Stimson Center, and others urge sustained “always-on” investment, better leadership/integration, equity focus, and domestic + global efforts. Preparedness is a continuous process, not a finished state—political will and resources determine outcomes more than plans alone. Monitoring H5N1, AMR, and emerging pathogens remains critical.

Citations (18)

  1. 1ghsindex.orgData and tools
    https://ghsindex.org/country/united-states/

    Backs: “Major gaps in coordination, funding, stockpiles sustainability, trust, equity, and sustained political commitment leave it vulnerable, and recent policy shifts have raised further concerns.”

  2. 2bit.lyCompanies
    https://bit.ly/2UrPEMn

    Backs: “It outperforms averages substantially in prevention, detection, and international norms compliance.”

  3. 3archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “Dramatically increased PPE (e.g., 70x N95s, 34x gloves, 50x gowns) and ventilators compared to pre-COVID levels; supported responses to H5N1 and mpox.”

  4. 4cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “Expanded electronic case reporting (from ~200 facilities pre-COVID to over 45,000–48,000), syndromic surveillance in most EDs, wastewater monitoring, and a “One CDC” data platform.”

  5. 5ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report

    Backs: “Created the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023; released National Biodefense Strategy, Global Health Security Strategy (2024), and a detailed roadmap/playbook; invested billions in global health security, vaccine/therapeutic development (including mRNA platforms and 100-days…”

  6. 6archives.govGovernment
    https://bidenwhitehouse.archives.gov/wp-content/uploads/2024/04/Global-Health-Security-Strategy-2024-1.pdf

    Backs: “Created the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023; released National Biodefense Strategy, Global Health Security Strategy (2024), and a detailed roadmap/playbook; invested billions in global health security, vaccine/therapeutic development (including mRNA platforms and 100-days…”

  7. 7apnews.comNews and mediaquality 1.00
    https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca

    Backs: “Advances via BARDA/ASPR, warm-base lab contracts, and stockpiling (e.g., H5N1 vaccine doses). Responses to mpox and H5N1 showed some operational gains.”

  8. 8biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “It calls for immediate action on leadership, intelligence/attribution, S&T, preparedness, detection/surveillance, and response/recovery, with dozens of recommendations. Fragmentation persists across agencies.”

  9. 9biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_.pdf

    Backs: “It calls for immediate action on leadership, intelligence/attribution, S&T, preparedness, detection/surveillance, and response/recovery, with dozens of recommendations. Fragmentation persists across agencies.”

  10. 10stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Coordination between PHEP (public health) and HPP (hospital) programs needs improvement.”

  11. 11gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Coordination between PHEP (public health) and HPP (hospital) programs needs improvement.”

  12. 12center-forward.orgNonprofits and think tanks
    https://center-forward.org/wp-content/uploads/2024/12/Final-Pandemic-Preparedness.docx.pdf

    Backs: “PAHPA reauthorization has faced delays/lapses; state/local public health funding is uneven or declining post-COVID supplemental funds.”

  13. 13statnews.comNews and mediaquality 0.82
    https://www.statnews.com/2024/09/16/h5n1-spread-cow-herds-us-response-who-pandemic-preparedness/

    Backs: “H5N1 response drew criticism for incomplete animal testing, farmer cooperation, and One Health (human-animal) integration.”

  14. 14tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “H5N1 response drew criticism for incomplete animal testing, farmer cooperation, and One Health (human-animal) integration.”

  15. 15reuters.comNews and mediaquality 1.00
    https://www.reuters.com/legal/litigation/us-rejects-who-pandemic-changes-global-health-rules-2025-07-18/

    Backs: “US investments helped create tools like JYNNEOS (mpox) and supported the Pandemic Fund, but withdrawal from or rejection of WHO IHR amendments/pandemic-related efforts, plus cuts to global programs, weakens early warning and containment abroad.”

  16. 16science.orgAcademic
    https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic

    Backs: “PAHPA modernization and hospital preparedness funding face uncertainty.”

  17. 17thinkglobalhealth.orgNonprofits and think tanks
    https://www.thinkglobalhealth.org/article/white-house-empties-office-us-pandemic-policy-gaps-left-behind

    Backs: “PAHPA modernization and hospital preparedness funding face uncertainty.”

  18. 18theguardian.comNews and mediaquality 0.75
    https://www.theguardian.com/us-news/2026/may/17/pandemic-preparedness-after-covid

    Backs: “PAHPA modernization and hospital preparedness funding face uncertainty.”